1.00 / AMA PRA Category 1 CreditTM 1.00 / ANCC Contact Hour
Jointly provided by Med Learning Group and Ultimate Medical Academy/Complete Conference Management
This activity is supported by an educational grant from Sanofi Genzyme and Regeneron.
Recognizing the Connection: A View Into the Parallels Between Asthma and Nasal Polyps – Treatment Minutes is an enduring activity which will cover the diagnosis, treatment, and management of patients with asthma and the correlation between asthma and nasal polyps. This CME initiative is designed to meet the educational needs of otolaryngologists and pulmonologists involved in the healthcare of patients with severe asthma and nasal polyps. The format mimics the popular Sixty Minutes documentary show and includes a moderator and faculty panel including physicians in Allergy & Immunology, Otolaryngology and Pediatric Otolaryngology, and Pulmonary, Critical Care & Sleep Medicine.
Otolaryngologists and pulmonologists involved in the healthcare of patients with severe asthma and nasal polyps
Upon completion of the program, participants should be able to:
Discuss the molecular biology underlying the inflammation of asthma and nasal polyps and associated therapeutic targets
Reveal potential therapeutic points of collaboration between pulmonologists and otolaryngologists
Assess patients’ level of control, severity of disease, and exacerbation risk in the management of asthma, reveal the commonalities between asthma and nasal polyps, and discuss potential patient specific treatment options
Describe the clinical trial data of current and emerging antibody targeted therapies and potential biomarkers for patients with moderate-to-severe asthma and nasal polyps
Conflict Of Interest Disclosure Policy
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
John Cohn, MD Professor Director, Allergy & Immunology Thomas Jefferson University Hospitals Philadelphia, PA
Dr. Cohn discloses he has worked on PI in past year on studies sponsored by Teva, AZ, GSK, and Sanofi.
Robert Naclerio, MD Professor of Surgery Otolaryngology and Pediatric Otolaryngology University of Chicago Chicago, IL
Dr. Naclerio discloses he has received consulting fees from Sanofi and is on the speakers’ bureau for Optinose.
Michael Wechsler, MD, MMSc Director, Asthma Program Professor of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Department of Medicine National Jewish Health Denver, CO
Dr. Wechsler discloses he is a consultant and has received honoraria from GlaxoSmithKline, Boston Scientific, Teva, Boehringer Ingelheim, Novartis, Vectura, Theravance, Sanofi/Regeneron, and Astrazeneca. He is an investigator for Sanofi/Regeneron. He has received a grant from Sanofi/Regeneron.
AMA PRA Category 1 Credit(s)TM
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Med Learning Group designates this enduring activity for a maximum of 1.00 AMA Category 1 Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
CNE Contact Hour(s)
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This program would be beneficial for nurses involved in the healthcare of patients with severe asthma and nasal polyps. This program provides 1.00 ANCC Contact Hour.
Disclosure of Unlabeled Use
Med Learning Group require that faculty participating in any CME/CNE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.